가톨릭대학교가톨릭대학교인공지능학과

 

교수진

겸무교원

안내사항

  • 교수진 정보는 아래 노출 순서 기준에 따라 정렬 되었습니다.

    * 노출 순서 기준 : 학과명순 - 직위순 - 입사일순 - 이름순

박선경(Sun-Kyeong Park) 프로필 이미지

박선경 조교수

Sun-Kyeong Park

연구분야

보건사회약학

연구키워드

약물경제성평가 및 빅데이터 활용 건강성과연구

교수소개


						
Health economics and outcomes research (HEOR) 연구를 수행하며, 상세 연구방법으로는 체계적 문헌고찰 및 네트워크 메타분석, 약물경제성평가, 빅데이터 분석연구가 있다. 그 외에도 방문약료 사업, 마약으로 인한 기소유예자 교육과 같은 약사 중재에 대한 성과에 대한 연구도 수행중이다. 한국보건사회약료경영학회, 한국보건의료기술평가학회, 한국약사커뮤니케이션과 커뮤니티케어학회의 임원으로 활동중이다.
Dr.Sun-Kyeong Park is interested in Health economics and outcomes research (HEOR), employing methodologies such as systematic literature reviews and network meta-analyses, pharmacoeconomics, and big-data analysis studies. Additionally, she has conducted research on the outcomes of pharmacist interventions (e.g., pharmacist home-visit service and diversion programs).

최종학력

2017.02.24 | 성균관대학교 | 약학대학 | 약학박사

연구실적

  • 2024.06 | 교신저자 | VACCINE, 제42권 22호, pp.126000-126000
    Cost-effectiveness analysis of the 20-valent pneumococcal conjugate vaccine for the pediatric population in South Korea
  • 2024.06 | 교신저자 | VACCINE, 제42권 22호, pp.126000-126000
    Cost-effectiveness analysis of the 20-valent pneumococcal conjugate vaccine for the pediatric population in South Korea
  • 2024.05 | 공동저자 | BMJ SUPPORTIVE AND PALLIATIVE CARE, 제0권 0호, pp.0-0
    Haematological cancer versus solid tumour end-of-life care: a longitudinal data analysis
  • 2024.04 | 교신저자 | INTERNATIONAL JOURNAL OF CARDIOLOGY, 제400권, pp.131786-131786
    Comparative efficacy of vericiguat to sacubitril/valsartan for patients with heart failure reduced ejection fraction: Systematic review and network meta-analysis
  • 2024.04 | 교신저자 | INTERNATIONAL JOURNAL OF CARDIOLOGY, 제400권
    Comparative efficacy of vericiguat to sacubitril/valsartan for patients with heart failure reduced ejection fraction: Systematic review and network meta-analysis
  • 2024.03 | 제1저자 | AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 제24권 2호, pp.313-324
    Eligibility and Cost-Utility Analysis of Dapagliflozin in Patients with Heart Failure Across the Whole Spectrum of Ejection Fraction in South Korea
  • 2024.02 | 교신저자 | VACCINE, 제42권 4호, pp.871-878
    Cost-effectiveness of the 20-valent pneumococcal conjugate vaccine versus the 23-valent pneumococcal polysaccharide vaccine for older adults in South Korea
  • 2024.01 | 제1저자 | JOURNAL OF KOREAN MEDICAL SCIENCE, 제39권 1호, pp.8-8
    Real-World Eligibility and Cost-Effectiveness Analysis of Empagliflozin for Heart Failure in Korea
  • 2024.01 | 제1저자 | ESMO OPEN, 제9권 1호, pp.102200-102200
    Effectiveness of next-generation sequencing for patients with advanced non-small-cell lung cancer: a population-based registry study
  • 2023.12 | 제1저자 | DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS, 제17권
    Comparison of Perceived Importance and Performance of Community Pharmacists' Role in South Korea During the Coronavirus Disease 2019 Pandemic
  • 2023.09 | 공동저자 | JOURNAL OF HOSPITAL INFECTION, 제139권, pp.249-250
    Impact of β-lactam allergies on antibiotic use, clinical outcomes, and economic costs in patients receiving surgical prophylactic antibiotics
  • 2023.09 | 공동저자 | JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 제29권 6호, pp.1016-1024
    Hospital outcomes and costs for prostate cancer patients with comorbid heart failure by age group: An analysis of the US Nationwide Inpatient Sample
  • 2023.07 | 교신저자 | CLINICAL DRUG INVESTIGATION, 제43권 7호, pp.463-474
    Systematic Review of the Economic Evaluation of Sodium-Glucose Cotransporter-2 Inhibitors Used as Treatment in Patients with Heart Failure
  • 2023.06 | 공동저자 | 약 학 회 지, 제67권 3호, pp.189-196
    건강보험청구자료를 이용한 HER2 양성 전이성 유방암 환자의 조기 사망에 따른 간접적 질병 부담 분석
  • 2022.11 | 제1저자 | NICOTINE AND TOBACCO RESEARCH, 제24권 12호, pp.2011-2017
    Cost-Effectiveness Analysis of Smoking Cessation Interventions With Behavioral Support: A Study Based on the Benefits of Smoking Cessation on Outcomes (BENESCO) Model
  • 2022.07 | 제1저자 | EXPERT OPINION ON PHARMACOTHERAPY, 제23권 11호, pp.1247-1257
    A systematic review of economic evaluations of tyrosine kinase inhibitors for non-small cell lung cancer (NSCLC)
  • 2022.05 | 공동저자 | QUALITY OF LIFE RESEARCH, 제31권 5호, pp.1345-1357
    Health-related quality of life among elderly breast cancer patients treated with adjuvant endocrine therapy: a U.S Medicare population-based study
  • 2021.12 | 공동저자 | CURRENT MEDICAL RESEARCH AND OPINION, 제37권 12호, pp.2043-2047
    In-hospital mortality, length of stay and hospital costs for hospitalized breast cancer patients with comorbid heart failure in the USA
  • 2021.06 | 제1저자 | AMERICAN JOURNAL OF MANAGED CARE, 제27권 6호, pp.E181-+
    Hospital Outcomes of Male Breast Cancer in the United States
  • 2021.05 | 공동저자 | EXPERT REVIEW OF PHARMACOECONOMICS AND OUTCOMES RESEARCH, 제21권 3호, pp.381-393
    Cost-effectiveness analyses of targeted therapy and immunotherapy for advanced non-small cell lung cancer in the United States: a systematic review
  • 2021.05 | 제1저자 | EXPERT REVIEW OF PHARMACOECONOMICS AND OUTCOMES RESEARCH, 제21권 3호, pp.395-402
    Association of congestive heart failure with hospital outcomes among renal cancer patients in the United States: analysis of nationwide inpatient sample
  • 2021.02 | 공동저자 | JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 제46권 1호, pp.35-49
    A network meta-analysis of efficacy and safety of first-line and second-line therapies for the management of metastatic renal cell carcinoma
  • 2020.12 | 공동저자 | JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 제26권 6호, pp.1677-1688
    Association of depression with adherence to breast cancer screening among women aged 50 to 74 years in the United States
  • 2020.11 | 교신저자 | CURRENT MEDICAL RESEARCH AND OPINION, 제36권 11호, pp.1825-1833
    The economic impact of disease progression and death in hormone receptor positive (HR plus ), human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer patients: using Korean nationwide health insurance claims data
  • 2019.12 | 제1저자 | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 제34권 12호, pp.2135-2143
    Beyond uncertainty: Negative findings for the association between the use of proton pump inhibitors and risk of dementia
  • 2019.11 | 제1저자 | EXPERT REVIEW OF PHARMACOECONOMICS AND OUTCOMES RESEARCH, 제19권 6호, pp.633-643
    Economic evaluations of oral medications for breast cancer treatment in the US: a systematic review with a focus on cost-effectiveness threshold
  • 2019.11 | 공동저자 | JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY: IN PRACTICE, 제7권 8호, pp.2642-2642
    A Comparison of Leukotriene Receptor Antagonists to Low-Dose Inhaled Corticosteroids in the Elderly with Mild Asthma
  • 2019.06 | 제1저자 | CLINICAL THERAPEUTICS, 제41권 6호, pp.1066-1079
    Cost-Utility Analysis of Sacubitril/Valsartan Use Compared With Standard Care in Chronic Heart Failure Patients With Reduced Ejection Fraction in South Korea
  • 2018.08 | 공동저자 | CLINICAL DRUG INVESTIGATION, 제38권 8호, pp.727-736
    The Utility of 5 Hypothetical Health States in Heart Failure Using Time Trade-Off (TTO) and EQ-5D-5L in Korea
  • 2018.06 | 제1저자 | DRUG SAFETY, 제41권 6호, pp.615-624
    The Uncertainty of the Association Between Proton Pump Inhibitor Use and the Risk of Dementia: Prescription Sequence Symmetry Analysis Using a Korean Healthcare Database Between 2002 and 2013
  • 2017.01 | 제1저자 | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 제35권, pp.689-699
    A comparison of discontinuation rates of tofacitinib and biologic disease-modifying anti-rheumatic drugs in rheumatoid arthritis: a systematic review and Bayesian network meta-analysis regression
  • 2017.01 | 공동저자 | EXPERT REVIEW OF PHARMACOECONOMICS AND OUTCOMES RESEARCH, 제17권 4호, pp.411-419
    Eliciting societal preferences of reimbursement decision criteria for anti cancer drugs in South Korea
  • 2016.11 | 제1저자 | CLINICAL THERAPEUTICS, 제37권 11호, pp.2430-2446
    Cost-effectiveness Analysis of Treatment Sequence Initiating With Etanercept Compared With Leflunomide in Rheumatoid Arthritis: Impact of Reduced Etanercept Cost With Patent Expiration in South Korea
  • 2015.08 | 공동저자 | CLINICAL THERAPEUTICS, 제37권 8호, pp.1662-1676
    Cost-effectiveness of Tofacitinib in the Treatment of Moderate to Severe Rheumatoid Arthritis in South Korea
  • 2015.03 | 제1저자 | 한국임상약학회지, 제25권 1호, pp.9-17
    Conventional DMARDs 치료에 실패한 류마티스 관절염 환자에서 Biologic DMARDs의 임상적 효과 비교: 베이지안 네트워크 메타분석
  • 2014.05 | 공동저자 | ARCHIVES OF PHARMACAL RESEARCH, 제37권, pp.662-670
    Comparative effectiveness of cycling of tumor necrosis factor-alpha (TNF-alpha) inhibitors versus switching to non-TNF biologics in rheumatoid arthritis patients with inadequate response to TNF-alpha inhibitor using a Bayesian approach
  • 2023.09 | 공동 | 범문에듀케이션
    약무행정과 경영관리
  • 2023.03 | 공동 | 자유아카데미
    보건의료 빅데이터 연구방법론 : 국내 보건의료 빅데이터 활용 연구방법부터 머신러닝 분석까지
  • 2022.09 | 공동 | 범문에듀케이션
    약사윤리학
산업과제
2021년 심부전에서의 OOO의 경제성평가(한국OOO제약)
2021년 ATTR-CM 환자 진단에서 심내막심근생검 대비 scintigraphy의 경제성평가(한국OOO제약)
2021년 아토피 치료에 대한 OOO의 간접비교(한국OOO제약)
2021년 아토피 치료에서 OOO 사용에 대한 재정영향분석(한국OOO제약)
2022년 OOOO 백신접종에 대한 경제성평가(한국OOO제약)
2024년 OOOO의 경제성평가(한국OOO제약)